NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ElkosRx, LLC

ElkosRx, LLC

Private
Hershey, PennsylvaniaHealthcare & Life Scienceshttps://www.elkospharma.com/

Last Round

Follow-on Offering

Jun 10, 2026

Total Funding Raised

$139.18M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ElkosRx, LLC is a biotechnology company developing a topical treatment for early-stage diabetic foot ulcers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

diabetic foot ulcersDFUtopical naltrexonewound healingbiotechnologyclinical-stage biotechwound managementOGFr inhibitordrug developmentchronic wound careinvestigational drugbiotech startupclinical trialstopical therapeutic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ElkosRx, LLC Comparables

Compare ElkosRx, LLC with similar companies based on industry and business-model similarity.

ElkosRx, LLC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Remedor Biomed Ltd.
84%
Lynch Regenerative Medicine
82%
Aurealis Therapeutics
78%

ElkosRx, LLC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Follow-on OfferingJun 10, 2026
DebtJul 10, 2024
PIPESep 20, 2023
DebtOct 5, 2021
Series CAug 2, 2017

ElkosRx, LLC Investors

Notable investors and investment history

ElkosRx, LLC investors
InvestorRounds
Hercules CapitalDebt
DSC InvestmentSeries C
EQT Life SciencesSeries C
Korea Investment PartnersSeries C
Pontifax Venture CapitalSeries C
OPKO HealthSeries C
Quark VentureSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 10, 2026

    $66M raised in follow-on offering.

  • Sep 20, 2023

    Raised $2M in a PIPE round.

ElkosRx, LLC Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ElkosRx, LLC Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ElkosRx, LLC's valuation, stock price, and market status.

Firmographic Details

HeadquartersHershey, Pennsylvania
Year Founded2021
Last FundingJun 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.